Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Ginsenoside Rg1 attenuates dextran sodium sulfate-induced ulcerative colitis in mice

Y. Chen, Q. Zhang, L. Sun, H. Liu, J. Feng, J. Li, Z. Wang

. 2023 ; 72 (6) : 783-792. [pub] 20231231

Language English Country Czech Republic

Document type Journal Article

Ulceration colitis (UC) is a chronic and recurrent inflammatory disorder in the gastro-intestinal tract. The purpose of our study is to explore the potential mechanisms of ginsenoside Rg1 (GS Rg1) on dextran sulfate sodium (DSS)-induced colitis in mice and lipopolysaccharide (LPS)-induced RAW 264.7 cells. Acute colitis was induced in male C57BL/6 mice. In vitro model of LPS-induced RAW 264.7 cells to simulate enteritis model. The disease activity index (DAI), colon length, body weight and histopathological analysis were performed in vivo. Pro-inflammatory cytokines and markers for oxidative and anti-oxidative stress, MPO level were measured in vivo and in vitro. Nuclear erythroid 2-related factor 2 (Nrf2) and NF-?B p65 protein levels were analyzed using western blotting. Our results indicated that the UC models were established successfully by drinking DSS water. GS Rg1 significantly attenuated UC-related symptoms, including preventing weight loss, decreasing DAI scores, and increasing colon length. GS Rg1 ameliorated the DSS-induced oxidative stress. IL-1beta, IL-6, and TNF-alpha levels were significantly increased in serum and cell supernatant effectively, while treatment with the GS Rg1 significantly reduced these factors. GS Rg1 reduced MPO content in the colon. GS Rg1 treatment increased SOD and decreased MDA levels in the serum, colon, and cell supernatant. GS Rg1 restored the Nrf-2/HO-1/NF-?B pathway in RAW 264.7 cells and UC mice, and these changes were blocked by Nrf-2 siRNA. Overall, GS Rg1 ameliorated inflammation and oxidative stress in colitis via Nrf-2/HO-1/NF-kappaB pathway. Thus, GS Rg1 could serve as a potential therapeutic agent for the treatment of UC.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24003168
003      
CZ-PrNML
005      
20250416104655.0
007      
ta
008      
240220s2023 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.935182 $2 doi
035    __
$a (PubMed)38215064
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Chen, Y. $u Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P.R. China
245    10
$a Ginsenoside Rg1 attenuates dextran sodium sulfate-induced ulcerative colitis in mice / $c Y. Chen, Q. Zhang, L. Sun, H. Liu, J. Feng, J. Li, Z. Wang
520    9_
$a Ulceration colitis (UC) is a chronic and recurrent inflammatory disorder in the gastro-intestinal tract. The purpose of our study is to explore the potential mechanisms of ginsenoside Rg1 (GS Rg1) on dextran sulfate sodium (DSS)-induced colitis in mice and lipopolysaccharide (LPS)-induced RAW 264.7 cells. Acute colitis was induced in male C57BL/6 mice. In vitro model of LPS-induced RAW 264.7 cells to simulate enteritis model. The disease activity index (DAI), colon length, body weight and histopathological analysis were performed in vivo. Pro-inflammatory cytokines and markers for oxidative and anti-oxidative stress, MPO level were measured in vivo and in vitro. Nuclear erythroid 2-related factor 2 (Nrf2) and NF-?B p65 protein levels were analyzed using western blotting. Our results indicated that the UC models were established successfully by drinking DSS water. GS Rg1 significantly attenuated UC-related symptoms, including preventing weight loss, decreasing DAI scores, and increasing colon length. GS Rg1 ameliorated the DSS-induced oxidative stress. IL-1beta, IL-6, and TNF-alpha levels were significantly increased in serum and cell supernatant effectively, while treatment with the GS Rg1 significantly reduced these factors. GS Rg1 reduced MPO content in the colon. GS Rg1 treatment increased SOD and decreased MDA levels in the serum, colon, and cell supernatant. GS Rg1 restored the Nrf-2/HO-1/NF-?B pathway in RAW 264.7 cells and UC mice, and these changes were blocked by Nrf-2 siRNA. Overall, GS Rg1 ameliorated inflammation and oxidative stress in colitis via Nrf-2/HO-1/NF-kappaB pathway. Thus, GS Rg1 could serve as a potential therapeutic agent for the treatment of UC.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a ulcerózní kolitida $x chemicky indukované $x farmakoterapie $x metabolismus $7 D003093
650    _2
$a dextrany $x metabolismus $x farmakologie $x terapeutické užití $7 D003911
650    _2
$a kolon $x metabolismus $7 D003106
650    _2
$a lipopolysacharidy $x metabolismus $7 D008070
650    _2
$a myši inbrední C57BL $7 D008810
650    12
$a kolitida $x chemicky indukované $7 D003092
650    _2
$a NF-kappa B $x metabolismus $7 D016328
650    _2
$a síran dextranu $x toxicita $x metabolismus $7 D016264
650    _2
$a modely nemocí na zvířatech $7 D004195
650    12
$a sírany $7 D013431
650    12
$a ginsenosidy $7 D036145
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zhang, Q. $u Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P.R. China
700    1_
$a Sun, L. $u Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P.R. China
700    1_
$a Liu, H. $u Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P.R. China
700    1_
$a Feng, J. $u Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P.R. China
700    1_
$a Li, J. $u Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P.R. China
700    1_
$a Wang, Z. $u Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P.R. China
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, č. 6 (2023), s. 783-792
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38215064 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20240220 $b ABA008
991    __
$a 20250416104700 $b ABA008
999    __
$a ok $b bmc $g 2302947 $s 1212908
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 72 $c 6 $d 783-792 $e 20231231 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
LZP    __
$b NLK116 $a Pubmed-20240220

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...